Catecholaminergic Polymorphic Ventricular Tachycardia: Difference between revisions

m
no edit summary
mNo edit summary
mNo edit summary
Line 21: Line 21:
** the CASQ2 gene, coding for the calsequestrine protein: ([[w:OMIM|OMIM™]] link {{OMIM2|114251}}) (1-2 % of patients)
** the CASQ2 gene, coding for the calsequestrine protein: ([[w:OMIM|OMIM™]] link {{OMIM2|114251}}) (1-2 % of patients)


'''Treatment'''
'''Treatment'''<cite>ACC2006</cite>
Treatment consist of:<cite>ACC2006</cite>
* Beta-blockers
* Beta-blockers
* [[w:nl:Internal_Cardiac_Defibrillator|ICD]] implantation combined with beta-blockers in CPVT patients who survived a cardiac arrest.<cite>sumitomo</cite>
* [[w:nl:Internal_Cardiac_Defibrillator|ICD]] implantation combined with beta-blockers in CPVT patients who survived a cardiac arrest.<cite>sumitomo</cite>